Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tenon Medical (TNON) EBITDA Margin (2021 - 2025)

Tenon Medical has reported EBITDA Margin over the past 5 years, most recently at 191.22% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 20969.0% year-over-year to 191.22%; the TTM value through Dec 2025 reached 318.36%, up 9748.0%, while the annual FY2025 figure was 318.36%, 9748.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 191.22% at Tenon Medical, up from 284.65% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 191.22% in Q4 2025 and troughed at 7568.18% in Q2 2021.
  • A 5-year average of 1750.81% and a median of 536.32% in 2023 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: crashed -198075bps in 2022 and later skyrocketed 352618bps in 2023.
  • Year by year, EBITDA Margin stood at 5424.53% in 2021, then skyrocketed by 48bps to 2829.24% in 2022, then soared by 87bps to 380.94% in 2023, then fell by -5bps to 400.91% in 2024, then surged by 52bps to 191.22% in 2025.
  • Business Quant data shows EBITDA Margin for TNON at 191.22% in Q4 2025, 284.65% in Q3 2025, and 490.96% in Q2 2025.